NYSE: BHVN       Biohaven Pharmaceutical Holding Company Ltd
Last Price Today's Change   Day's Range   Trading Volume
51.48   -4.96 (8.79%)  50.40 - 52.28  2,973,458


Avg Volume (4 weeks):784,227
4 Weeks Range:50.40 - 59.65
4 Weeks Price Volatility (%):
52 Weeks Range:34.30 - 67.86
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders. The company's product candidates are small molecules based on two distinct mechanistic platforms-calcitonin gene-related peptide, or CGRP, receptor antagonists and glutamate modulators-which it believes has the potential to significantly alter existing treatment approaches across a diverse set of neurological indications. The most advanced product candidate from the company's CGRP receptor antagonist platform is rimegepant, which it is developing for the acute treatment of migraine. The most advanced product candidate from glutamate modulation platform is trigriluzole.

  Be the first to like this.


2222  3402  415  2925 

Top 10 Active Counters
 CELG 108.24+0.11 
 GE 12.96+1.23 
 ACHN 6.760.00 
 AMD 46.843-3.687 
 CHK 0.563+0.045 
 AVP 5.60-0.05 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 ECA 3.79-0.25 
 AAPL 326.42+8.73 
Partners & Brokers